Misuse-resistive transdermal opioid dosage form
June 14, 2011. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesMedical bandage Method of administering narcotic antagonists and analgesics and novel dosage forms containing same Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine Transdermal administration of fentanyl and device therefor Trandermal delivery of opioids Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration User-activated transdermal therapeutic system Treating opiate dependence Patent #: 4935428 InventorsAssigneeApplicationNo. 716037 filed on 06/14/1991US Classes:424/449, Transdermal or percutaneous424/484, Matrices424/486Synthetic polymerExaminersPrimary: Page, Thurman K.Assistant: Levy, Neil S. Attorney, Agent or FirmForeign Patent References
International ClassesA61K 009/70A61K 031/485 AbstractA misuse-resistive dosage form for the transdermal delivery of opioid comprises, in combination, 1) one or more opioid permeable to the skin, 2) delivery means permeable to said opioid, 3) one or more antagonist for said opioid releasable upon ingestion or solvent immersion, and 4) impermeable barrier means separating said opioid and said antagonist. | |
